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Abstract. The potential of mass spectrometric peptide identification in complex 
mixtures by means of peptide mass fingerprinting (PMF) and peptide fragment 
fingerprinting (PFF) was evaluated and compared utilizing synthetic mixtures 
of commercially available proteins and electrospray-ion trap- or electrospray 
time-of-flight mass spectrometers. While identification of peptides by PFF is 
fully supported by automated spectrum interpretation and database search 
routines, reliable identification by PMF still requires substantial efforts of 
manual calibration and careful data evaluation in order to avoid false positives. 
Quantitation of the identified peptides, however, is preferentially performed 
utilizing full-scan mass spectral data typical of PMF. For the absolute 
quantitation of serum proteins, we have developed an analytical scheme based 
on first-dimension separation of the intact proteins by anion-exchange high-
performance liquid chromatography (HPLC), followed by proteolytic digestion 
and second-dimension separation of the tryptic peptides by reversed-phase 
HPLC in combination with electrospray ionization mass spectrometry (ESI-
MS). 
1   Mass spectrometric peptide identification 
1.1   Peptide Mass Fingerprinting 
In the Peptide Mass Fingerprinting (PMF) approach, the complex protein mixture one 
wants to analyze is generally enzymatically digested with a specific enzyme such as 
trypsin. After protein digestion, the resulting complex peptide mixture is usually 
separated by two-dimensional high-performance liquid chromatography (2D-HPLC). 
The separated peptides are then ionized with soft ionization methods such as matrix-
assisted laser desorption/ionization (MALDI) or electrospray ionization (ESI) and 
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analyzed by mass spectrometry (MS). In this approach, a peptide is identified by 
measuring its mass over charge ratio (m/z) and by comparing it to a list of m/z 
calculated from a list of peptides generated from in silico digestion of the proteins in a 
database. Protein identification occurs when one or more peptides matching a part of 
the protein sequence are identified. In this approach, the identification of a peptide is 
only based on a single m/z measurement. To get high confidence results, it is of 
importance to get very accurate m/z values (3-5 ppm mass deviation) and to use high-
resolution mass analyzers such as time-of-flight (TOF) or Fourier Transform Ion 
Cyclotron Resonance (FT-ICR) being able to differentiate lysine (m/z 128.095) from 
glutamine (m/z 128.059). Anyways, to get the best mass accuracy it is recommended 
to perform internal mass recalibration. This procedure is, however, time consuming 
for the operator and seldomly automated. 
1.2   Peptide Fragment Fingerprinting 
In the Peptide Fragment Fingerprinting (PFF) approach, the complex protein mixture 
one to be analyzed is digested and separated as in the previously described PMF 
approach. The difference appears in the mass spectrometric detection. After MALDI 
or ESI ionization, peptides are fragmented in the gas phase. The fragments obtained in 
the gas phase are finally separated, detected, and compared to sets of theoretical 
fragments. Theoretical fragments are obtained from in silico fragmentation of 
peptides, according to fragmentation rules and the type of instrument used for the 
fragmentation. In this approach, a peptide is identified with by the mass of the intact 
precursor peptide ion, but also by the m/z of each fragment observed in the spectrum. 
For this reason it is possible to get unambiguous peptide and protein identification 
without high accuracy mass instruments. 
1.3   Peptide Mass Fingerprinting vs. Peptide Fragment Fingerprinting 
23 commercially available proteins were used to prepare synthetic mixtures of 
proteins. These mixtures were proteolytically digested with trypsin after denaturation 
with urea and cystein carboxymethylation. The resulting peptide mixtures were 
individually separated on a 200 µm i.d. poly-(styrene-divinylbenzene) (PS-DVB) 
monolithic column coupled to an ESI ion-trap mass spectrometer performing data-
dependent auto-MS/MS analysis of the most intensive ions. The same mixtures were 
also separated on the PS-DVB column coupled to an ESI time-of-flight mass 
spectrometer. Mass spectra of both HPLC run sets were computed for identification 
with MASCOT (http://www.matrixscience.com). In the PMF approach (MS with 
time-of-flight analyzer) 438 peptides were identified as only 226 were found 
significant with the PFF approach (MS/MS with ion-trap analyzer). The results sum 
up the advantages and the disadvantages of the two methods. With PMF, more 
peptides are identified but despite mass spectra recalibration and high accuracy mass 
measurement, false positive hits might be reported. This approach is also practically 
difficult to analyze complex mixtures of unknown compounds. The number of 
undistinguishable peptides is substantially increasing with the size of the database. On 
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the contrary, PFF delivers high confidence identification data but at the cost of a 
smaller number of identifications. 
2   Absolute quantitation of myoglobin in serum 
The serum complexity makes the absolute quantitative analysis of medium to low-
abundant proteins very challenging. Tens of thousands proteins are present in human 
serum and dispersed over an extremely wide dynamic range. The reliable 
identification and quantitation of proteins, which are potential biomarkers of disease, 
in serum or plasma as matrix still represents one of the most difficult analytical 
challenges (Chelius, Zhang et al., 2003;Bondarenko, Chelius et al., 2002;Chelius & 
Bondarenko, 2002). The difficulties arise from the presence of a few, but highly 
abundant proteins in serum and from the non-availability of isotope-labeled proteins, 
which serve to calibrate the method and to account for losses during sample 
preparation. An analytical scheme for the absolute quantitative analysis of myoglobin 
was developed.  
2.1   Myoglobin biological activity 
Myoglobin is a 17 kDa protein which permits the oxygen storage of primary aerobic 
working muscles such as heart. The protein is made of a single polypeptide chain of 
153 amino acids. The property of myoglobin to bind oxygen molecules is due to the 
presence of a heme group. This non-covalent group made of a porphyrin ring is able 
to complex iron and is responsible for the red color of myoglobin. The dimensions of 
the protein measured in solution are: 4.5 x 3.5 x 2.5 nm. The tertiary structure of the 
protein is mostly α-helical; eight α-helical portions are separated by unarranged 
structures. Two histidine residues inside the natural protein play a decisive role for the 
binding of oxygen on the heme group. When a muscle (e.g. heart muscle) is injured, 
myoglobin is released into serum. Such a case occurs during myocardial infarction. 
After 2 hours, the plasma myoglobin concentration rises, and after 6-9 hours a 
concentration peak is reached (200 – 1000 ng/mL plasma) (Kilpatrick, Wosornu et al., 
1993;Bhayana, Cohoe et al., 1994;Beuerle, Azzazy et al., 2000). After 12-24 hours 
the myoglobin concentration recovers a value of 3 -65 ng /mL. 
2.2   Myoglobin absolute quantitation 
In our approach, a human serum sample was spiked with horse myoglobin as internal 
standard. The sample was also spiked with different concentrations of human 
myoglobin to perform a quantitation based on the method of standard additions. The 
sample was injected over a strong-anion-exchange (SAX) chromatography column 
and a fraction corresponding to myoglobin elution was collected. The fraction 
containing myoglobin as intact protein was digested with trypsin. The resulting 
peptides were injected over a 200 µm PS-DVB monolithic column hyphenated to an 
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ESI ion-trap mass spectrometer monitoring in full-scan mode. Extracted ion 
chromatograms corresponding to tryptic peptides of human and horse myoglobin 
were traced and areas of the eluting peaks were computed. It was possible to 
determine myoglobin concentrations in human serum down to 100-500 ng/mL. 
Calibration graphs were linear over at least one order of magnitude and the relative 
standard deviation of the method ranged from 7-15%. Compared to manual result 
computation, bioinformatic algorithms (OpenMS) led to a significant reduction both 
of absolute deviation and confidence interval (Gröpl. C., Lange et al., 2005). 
3   Conclusion 
According to our results for peptide identification and quantitation, algorithmic 
solutions for PMF that incorporate both recalibration and automated feature finding 
on the basis of peak elution profiles and isotopic patterns are highly desirable in order 
to speed up the process of data evaluation and calculation of quantitative results. 
Absolute quantification of protein in biological matrices is feasible upon calibration 
using additions of authentic analyte. Computer-based algorithms, based on modelling 
of peak volumes both in retention-time and m/z dimension result in a significant 
inmprovement in quantitative accuracy. 
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